Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Jun 18, 2021 1:12pm
141 Views
Post# 33411881

RE:RE:Misleading numbers, paint coming in a variety of #'s

RE:RE:Misleading numbers, paint coming in a variety of #'s"If we were listed for trading in the US this activity wouldn't occur..."

Perhaps you have inadvertantly put your finger on a key impediment to a Nasdaq listing?

Once again..  It's not that hard to list on Nasdaq, and thereby generate much more exposure in a key market (incidently the same market from which the vast majority of revenues for PMX and Dialco will ultimately be derived).

Liquidity, exposure, awareness, demand (insert other relevent word here _____)  does indeed spoil/limit/confound (insert other relevent word here _______)  manipulation efforts.  If one believes in their product and science, it should be a no brainer to put it on more full display.

Why wouldn't the management team (incl BoD) want to accomplish the goal of at least reducing manipulation efforts (or appearances of same), while at the same time improving value for all investors?

I can't beleive the westerners are loving the trading that is now below warrant exercise price.  Not a great use of cash in hindsight.

MM






<< Previous
Bullboard Posts
Next >>